XIENCE Skypoint™ 1804350-48Recalls & reported problems
Abbott Vascular Inc. · XIENCE Skypoint™ Everolimus Eluting Coronary Stent System 3.50 mm x 48 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE Skypoint (69)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 11
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 08717648231308), received between Jun 13, 2024 and Jun 17, 2026 — classified as 1 death, 1 injury, 9 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Dislodged or Dislocated4
- Improper or Incorrect Procedure or Method4
- Material Deformation4
- Difficult to Remove3
- Failure to Advance3
- Adverse Event Without Identified Device or Use Problem2
- Break2
- Difficult to Advance2
Patient problems
- No Clinical Signs, Symptoms or Conditions9
- Cardiac Arrest1
- Perforation of Vessels1
- Thrombosis/Thrombus1
Recent adverse event reports
The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 17, 2026Difficult to Remove; Improper or Incorrect Procedure or Method; Failure to Advance; Material Deformation
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A DE NOVO, HEAVILY CALCIFIED, MILDLY TORTUOUS RIGHT CORONARY ARTERY LESION. A 3.5X48 MM XIENCE SKYPOINT DRUG-ELUDING STENT DELIVERY SYSTEM (SDS) WAS ADVANCED TO THE TARGET LESION. HOWEVER, IT FAILED TO CROSS THE LESION. A GUIDELINER WAS INSERTED AND THE DES WAS ADVANCED AGAIN. HOWEVER, IT AGAIN FAILED TO CROSS THE LESION. DURING REMOVAL, RESISTANCE WAS NOTED BETWEEN THE SDS AND GUIDLINER, CAUSING THE EDGES OF THE STENT TO BE MANGLED. BOTH DEVICES WERE REMOVED TOGETHER. A NEW 3.5X48 MM XIENCE SKYPOINT SDS AND GUIDELINER WERE USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25539582 ↗MalfunctionMay 12, 2026Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A 71% STENOSED DE NOVO LESION IN THE LEFT ANTERIOR DESCENDING (LAD) ARTERY WITH MILD CALCIFICATION. THE 3.5 X 48 MM XIENCE SKYPOINT STENT WAS IMPLANTED ALTHOUGH THE STENT WAS NOTED TO BE EXPIRED. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY REPORTED IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25156786 ↗MalfunctionApr 10, 2026Break
IT WAS REPORTED THAT DURING PREPARATION OF THE 2.5X48 MM XIENCE SKYPOINT STENT DELIVERY SYSTEM (SDS), THE STENT FRACTURED IN 2 PLACES. THERE WAS NO REPORTED DEVICE USE OR PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24839366 ↗MalfunctionDec 1, 2025Off-Label Use; Difficult to Remove; Difficult to Advance; Device Dislodged or Dislocated; Off-Label Use; Difficult to Remove; Difficult to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE POSTERIOR TIBIAL ARTERY WITH HEAVY CALCIFICATION. THE 3.5X48MM XIENCE SKYPOINT STENT DELIVERY SYSTEM (SDS) WAS BEING ADVANCED TO THE TARGET LESION WHEN THE SDS BECAME SNAGGED ON THE GUIDE WIRE (GW). THEREFORE, THE SDS WAS REMOVED FROM THE PATIENT; HOWEVER, DURING REMOVAL THE STENT CAME OFF THE BALLOON AND AS A RESULT , THE DISLODGED STENT AND THE DELIVERY SYSTEM GW WERE REMOVED AS A SINGLE UNIT. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY REPORTED IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23684146 ↗MalfunctionOct 15, 2025Break; Failure to Advance; Material Deformation; Break; Failure to Advance; Material Deformation
RETURNED DEVICE ANALYSIS IDENTIFIED THAT THERE WERE NO BROKEN STRUTS, THEY WERE BENT. THE ACCOUNT CONFIRMED THAT THE CORRECT DEVICE WAS RECEIVED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23281133 ↗InjuryAug 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A HEAVILY CALCIFIED LESION IN THE LEFT ANTERIOR DESCENDING ARTERY (LAD). FOLLOWING ORBITAL ATHERECTOMY USING A DIAMONDBACK DEVICE, A 3.50 X 48MM XIENCE SKYPOINT DRUG ELUTING STENT WAS SUCCESSFULLY IMPLANTED AT THE LESION; HOWEVER, DURING POST-DILATATION USING A NC TREK BALLOON DILATATION CATHETER (DC), A PERFORATION WAS NOTED AND LOCATED WITHIN THE DEPLOYED STENT. THE PERFORATION WAS TREATED BY HOLDING COMPRESSION WITH THE NC TREK BDC AND PERFORMING PERICARDIOCENTESIS. A CLINICAL DELAY WAS NOTED AND THE PATIENT WAS REPORTED TO HAVE NO ADVERSE PATIENT SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Perforation of Vessels
MAUDE report 22889363 ↗MalfunctionMay 27, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE PROXIMAL LEFT ANTERIOR DESCENDING (PLAD) ARTERY. THE DRAGONFLY OPSTAR IMAGING CATHETER WAS ATTEMPTED TO BE USED BUT COULD NOT BE RECOGNIZED DISPLAYING MESSAGE "CATHETER NOT RECOGNIZED BY DEVICE" WITHOUT ERROR CODE. ANOTHER DRAGONFLY OPSTAR WAS USED INSTEAD TO CONTINUE THE PROCEDURE. THE 3.5X48MM XIENCE SKYPOINT STENT DELIVERY SYSTEM (SDS) WAS THEN BEING PREPARED WHEN THE STENT FELL OFF THE BALLOON. THE SDS WAS NOT USED IN THE PATIENT. A 3.5X38MM XIENCE SKYPOINT STENT WAS IMPLANTED SUCCESSFULLY. THE 3.5X23MM XIENCE SKYPOINT SDS WAS BEING ADVANCED WITHOUT RESISTANCE WHEN THE STENT WAS NOTED TO BE DEFORMED ON THE BALLOON AND FAILED TO CROSS. A 3.5X18MM XIENCE SKYPOINT STENT WAS IMPLANTED SUCCESSFULLY. THERE WAS NO ADVERSE PATIENT EFFECT AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22087521 ↗DeathMar 24, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THE PROCEDURE WAS TO TREAT LESIONS IN THE LEFT ANTERIOR DESCENDING (LAD) AND LEFT CIRCUMFLEX (LCX) ARTERIES. A 3.50X48MM AND A 3.50X38MM XIENCE SKYPOINT STENTS WERE IMPLANTED WITHOUT ISSUE. AT THE END THE PROCEDURE, THE PATIENT WAS AWAKE, ALERT, AND IN RECOVERY WITH FAMILY. HOWEVER, LATER THAT DAY THE PATIENT CODED AND WAS BROUGHT BACK TO THE CATH LAB WHERE ANGIOGRAPHY SHOWED THROMBUS IN THE LEFT MAIN (LM). A GUIDE WIRE WAS PLACED AND THROMBECTOMY WAS ATTEMPTED HOWEVER THE PATIENT EXPIRED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Cardiac Arrest; Thrombosis/Thrombus
MAUDE report 21677040 ↗MalfunctionJan 6, 2025Device Dislodged or Dislocated; Material Deformation; Device Dislodged or Dislocated; Material Deformation
IT WAS REPORTED THAT PRIOR TO USE OF THE 3.5X48MM XIENCE SKYPOINT STENT DELIVERY SYSTEM (SDS), WHEN THE STYLET WAS REMOVED, THE STENT MOVED COMPLETELY OFF THE DELIVERY BALLOON AND THE STRUTS WERE NOTED TO BE FLARED. THEREFORE, THE SDS WAS NO USED IN THE PATIENT. ANOTHER SAME SIZE XIENCE SKYPOINT WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO PATIENT INVOLVEMENT AND NO CLINICALLY SIGNIFICANT DELAY REPORTED IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21080654 ↗MalfunctionAug 22, 2024Improper or Incorrect Procedure or Method; Device Dislodged or Dislocated; Improper or Incorrect Procedure or Method; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED IN THE RIGHT CORONARY ARTERY (RCA). THE 3.5X48MM XIENCE SKYPOINT STENT DELIVERY SYSTEM (SDS) WAS BEING LOADED ONTO THE GUIDE WIRE AND CONNECTED TO THE INDEFLATOR WHEN IT WAS NOTED THAT THE STENT WAS ON THE TABLE. ANOTHER NON-ABBOTT STENT WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECT AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20034401 ↗MalfunctionJun 13, 2024Difficult to Remove; Improper or Incorrect Procedure or Method; Failure to Advance; Difficult to Advance; Material Deformation; Difficult to Remove; Improper or Incorrect Procedure or Method; Failure to Advance; Difficult to Advance; Material Deformation
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE MID RIGHT CORONARY ARTERY (MRCA) WITH HEAVY CALCIFICATION AND HEAVY TORTUOSITY. THE 3.5X48MM XIENCE SKYPOINT STENT DELIVERY SYSTEM (SDS) WAS ATTEMPTED TO BE ADVANCED TO THE TARGET LESION; HOWEVER, FAILED DUE TO THE ANATOMY AND RESISTANCE WITH THE GUIDELINER. THE SDS WAS REMOVED AND THE LESION WAS SHOCK WAVED. AN ADDITIONAL ATTEMPT WAS MADE TO CROSS THE SDS WITH THE USE OF A BUDDY WIRE, BUT WAS UNSUCCESSFUL. ADDITIONAL DILATATION WAS PERFORMED AND THE SDS WAS ATTEMPTED AGAIN, BUT WOULD NOT EXIT THE GUIDELINER. DURING REMOVAL, RESISTANCE WAS MET WITH THE GUIDE LINER. AFTER REMOVAL, THE DISTAL EDGE OF THE STENT BECAME FLARED. THE PROCEDURE WAS COMPLETED WITH 2 NON-ABBOTT STENTS. THERE WERE NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY REPORTED IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19530007 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page